## Abstract In order to better understand the relationship between IgA and IgG antibodies to EpsteinβBarr virus (EBV) in nasopharyngeal carcinoma (NPC), we analyzed 230 NPC sera but also a series of sera from patients with other carcinomas selected for their high EBV/IgG antibody titres. We were su
Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma
β Scribed by Ho, H C; Ng, M H; Kwan, H C; Chau, J C
- Book ID
- 109833542
- Publisher
- Nature Publishing Group
- Year
- 1976
- Tongue
- English
- Weight
- 665 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0007-0920
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Stimulated by a report on elevated IgA levels in nasopharyngeal carcinoma (NPC), we tested a total of 372 sera from patients with NPC, other carcinomas of head and neck or elsewhere, Burkitt's lymphoma (BL), infectious mononucleosis (IM) or healthy controls. The sera were titrated in in
The feasibility of using elevated Epstein-Barr virus (EBV) specific-IgG antiviral capsid antigen (VCA) and IgA anti-VCA antibody levels as an aid in diagnosis of nasopharyngeal carcinoma (NPC) was analyzed by determination of serum antibody titers to EBV in 54 NPC patients, 114 healthy blood donors,